(Q51806830)

English

Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial.

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial. (English)

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

author name string

Billur Canbakan

1

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Hakan Senturk

2

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Fehmi Tabak

3

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Meral Akdogan

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Ali Mert

6

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Necdet Sut

7

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Resat Ozaras

8

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Kenan Midilli

9

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Gulsen Ozbay

10

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

publication date

1 April 2006

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

21

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

4

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

657-663

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04082.X

21 January 2018

Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04082.X

21 January 2018

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04082.X

21 January 2018

Famciclovir treatment of chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04082.X

21 January 2018

Antiviral actions of interferons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04082.X

21 January 2018

Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04082.X

21 January 2018

Clinical pharmacokinetics of lamivudine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04082.X

21 January 2018

Changing pattern of chronic hepatitis D in Southern Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04082.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2006.04082.X

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

release_6eq7jzmhenhqxkowqcseu5asdu

1 reference

https://api.fatcat.wiki/v0/release/6eq7jzmhenhqxkowqcseu5asdu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

12 April 2018

http://europepmc.org/abstract/MED/16677149

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51806830&oldid=1838834241"